The FDA granted PeraHealth 510(k) clearance for PeraTrend, its clinical surveillance technology.

The real-time, predictive technology utilizes the Rothman Index to leverage data within a hospital’s electronic records to quantify and visualize patient risks, improvements and deterioration.

The index it utilizes uses a range of physiological measures, such as labs, vital signs and nursing assessments, to continuously measure a patient’s condition.